Tuesday, August 30, 2016

BRIEF-Valeant acquires Canadian rights for Contrave in treatment of obesity

Aug 30 (Reuters) - Valeant Pharmaceuticals International Inc

:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)